FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Zhao Hong 		2. Issuer Name and Ticker or Trading Symbol

SCICLONE PHARMACEUTICALS INC [ SCLN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CEO, China Operations
(Last)          (First)          (Middle)

950 TOWER LANE, SUITE 900 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/13/2017
(Street)

FOSTER CITY, CA 94404
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/13/2017     M    52000   A   (1) 52000   D    
Common Stock   10/13/2017     A    75000   (2) A $0.00   127000   D    
Common Stock   10/13/2017     D    127000   D $11.18   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   (3) $4.52   10/13/2017     D         90000      (4) 3/14/2024   Common Stock   90000   $6.66   (5) 0   D    
Non-Qualified Stock Option (right to buy)   (3) $8.83   10/13/2017     D         84000      (6) 3/16/2025   Common Stock   84000   $2.35   (5) 0   D    
Restricted Stock Unit   (3)   (1) 10/13/2017     M         6000      (7)   (7) Common Stock   6000     (1) 0   D    
Restricted Stock Unit   (3)   (1) 10/13/2017     M         25000      (7)   (7) Common Stock   25000     (1) 0   D    
Non-Qualified Stock Option (right to buy)   (8) $9.12   10/13/2017     D         84000      (9) 3/15/2026   Common Stock   84000   $2.06   (5) 0   D    
Restricted Stock Unit   (8)   (1) 10/13/2017     M         9000      (7)   (7) Common Stock   9000     (1) 0   D    
Restricted Stock Unit   (8)   (1) 10/13/2017     M         12000      (7)   (7) Common Stock   12000     (1) 0   D    
Non-Qualified Stock Option (right to buy)   (8) $9.65   10/13/2017     D         84000      (10) 3/8/2027   Common Stock   84000   $1.53   (5) 0   D    

Explanation of Responses:
(1)  Each restricted stock unit represented a contingent right to receive one share of SCLN common stock upon settlement.
(2)  Shares of SCLN common stock received in settlement of performance rights not constituting derivative securities.
(3)  Granted under Issuer's 2005 Equity Incentive Plan.
(4)  Under its terms the option became exercisable in installments with 25% vesting on March 14, 2015 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the "Merger").
(5)  The option was canceled immediately prior to the Merger in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price.
(6)  Under its terms the option became exercisable in installments with 25% vesting on March 16, 2016 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger.
(7)  Restricted stock units became fully vested and entitled to settlement immediately prior to the Merger and terminated upon settlement in shares of SCLN common stock.
(8)  Granted under Issuer's 2015 Equity Incentive Plan.
(9)  Under its terms the option became exercisable in installments with 25% vesting on March 15, 2017 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger.
(10)  Under its terms the option became exercisable in installments with 25% vesting on March 8, 2018 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Zhao Hong
950 TOWER LANE, SUITE 900
FOSTER CITY, CA 94404

CEO, China Operations

Signatures
/s/ Friedhelm Blobel, Attoney-in-Fact For: Hong Zhao 10/16/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Sciclone (NASDAQ:SCLN)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Sciclone Charts.
Sciclone (NASDAQ:SCLN)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Sciclone Charts.